Interpretation of Medical Agent System.docVIP

 PAGE \* MERGEFORMAT 9 Interpretation of Medical Agent System Merchants agent system development to date, in the pharmaceutical industry has established its own unique operating system. A small investment of its own business, operating risk, distribution channels, rapid etc., have already enjoys popular support. In particular, with the impact of the entire pharmaceutical industry, as many enterprises began to self-channel, hopes to earn more interest, we see that the industry group of investment agency continuous development and upgrading of enterprises. But it is undeniable that the investment operations of this multi-agency enterprise agent for the upstream producers to downstream products, post selling individual agents, and through the eventual realization of individual agents to sell drugs in patients with terminal or reach the hands of the agent system itself Indeed there are many unpredictable factors. 1, the lack of products in the market the depth of cultivation Looking at the current market pharmaceutical investment business operating in the product tend to achieve a product line business model. Select a category of products are often high-middle and low investment products work, and would not be as self-end manufacturer of a product, as in the above great efforts. Meanwhile, in large and small investment product catalog, there are numerous printed will always be a considerable number of products. Among these, there Quanguozongdai varieties, the variety of regional agents, of course, there are channels for transfer agent the nature of species and varieties. Small number of products seem to fear that no one agency of the same varieties of the same class will be different prices, packaging and different, several different manufacturers and even flooded with dozens of pictures, while adhering to a ‘full net, and focus on fishing tactics’ . This depend on the number of products for investment of the agent system model, ignore the advantages of a sin